Moderna shares soar following positive skin cancer vaccine news

Moderna shares surged nearly 88 percent on Wall Street following the announcement of positive clinical trial results for a new skin cancer vaccine. The study indicates that the vaccine effectively reduces the risk of cancer recurrence or spread.
